StockGlow

Veraxa Biotech AG (VRXA)

VERAXA Biotech AG develops antibody-based therapeutics and antibody-drug conjugates for cancer treatment.

$1.83-0.07%Healthcare
Compare VRXA with
StockGlow Score
3
Bearish
BearishBullish
1 year ago-82.4%

The outlook

Veraxa Biotech AG currently reads as bearish based on below its 50- & 200-day averages, 1% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range1% of the way from its 52-week low to high
Market cap
$258.8M
52-wk high
$27.36
52-wk low
$1.70
50-day avg
$6.58
200-day avg
$9.92
Trailing P/E
—

Similar stocks

MTENMingteng International Corporation Inc.$1.00-3.39%SUGPSU Group Holdings Limited$0.47-1.04%ELTXElicio Therapeutics, Inc.$2.86-1.72%PMAXPowell Max Limited$1.73+0.29%BIYABaiya International Group Inc.$4.02+11.42%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy